Analysis on the key points in the design and implementation of decentralized clinical trials
XIAO Shuang
LI Gao-yang
DONG Rui-hua
ZHU Xue-qi
WANG Jing
CAO Cai
CHENG Jin-lian
Abstract：Decentralized Clinical Trials(DCT),as one of the clinical trial modes that can be selected in patient-centered clinical trials,can significantly shorten the time course of entering market for new drugs or devices,improve the experience of clinical trial participants and enhance the quality of clinical data.However,DCT,like most new innovations,will increase the complexity of the clinical trial process and may also bring in unknown risks.This article explores the features and advantages,the feasibility of application,the factors to consider in design and implementation,elements,risk and countermeasure of DCT,in order to provide references and ideas for the practice of DCT.
Keywords：decentralized clinical trialapplicationdesignimplementation
Publication Date：2024-09-15
Online Publishing Date：2026-08-14(First online date of this platform, not the publication date of the document)
Pages：5( 1773-1777 )